SYSTEM LUPUS ERYTHEMATOSUS(SLE)

Clinical trials for SYSTEM LUPUS ERYTHEMATOSUS(SLE) explained in plain language.

Never miss a new study

Get alerted when new SYSTEM LUPUS ERYTHEMATOSUS(SLE) trials appear

Sign up with your email to follow new studies for SYSTEM LUPUS ERYTHEMATOSUS(SLE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 4 Not yet finished but already full! 1 Completed 1

Experimental CAR-T shot targets three tough autoimmune diseases

Disease control Recruiting now

This early study is testing an experimental therapy called EVM18001 in 12 people with active, hard-to-treat lupus, myasthenia gravis, or scleroderma. The main goal is to see if it is safe and to find the right dose. Researchers will also look at how the body processes the therapy…

Matched conditions: SYSTEM LUPUS ERYTHEMATOSUS(SLE)

Phase: NA • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control

Last updated Jun 27, 2026 11:01 UTC

SYSTEM LUPUS ERYTHEMATOSUS(SLE)

Get alerted when new SYSTEM LUPUS ERYTHEMATOSUS(SLE) trials appear

Experimental CAR-T shot targets three tough autoimmune diseases